Lexicon Pharmaceuticals (LXRX) Gross Margin Growth (5y) (2022 - 2025)

Lexicon Pharmaceuticals (LXRX) Gross Margin Growth (5y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Lexicon Pharmaceuticals 979.13 Mn 808.47 Mn 20.99 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -366.00
Jun 30, 2025 291,189.00
Mar 31, 2025 472.00
Dec 31, 2024 756.00
Sep 30, 2024 -386.00
Jun 30, 2024 14,422.00
Mar 31, 2024 1,984.00
Dec 31, 2023 -581.00
Sep 30, 2023 359.00
Jun 30, 2023 332.00
Jun 30, 2022 444.00